Skip to main content

Johnson Rady A's Form 4 filing

Pfizer Inc (PFE) · filed Dec 6, 2021

Accession no.
0001225208-21-014512
Filed
Dec 6, 2021
Trade date
Dec 3, 2021
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 11 non-derivative transactions. Open-market sales total $1.02M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Johnson Rady ACIK 0001594762Officer (Executive Vice President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 3, 2021Common StockSSaleDisposed−200$53.47−$10,69474,644Direct
Dec 3, 2021Common StockSSaleDisposed−300$53.51−$16,05374,344Direct
Dec 3, 2021Common StockSSaleDisposed−371$53.37−$19,800.2773,973Direct
Dec 3, 2021Common StockSSaleDisposed−400$53.41−$21,36473,573Direct
Dec 3, 2021Common StockSSaleDisposed−500$53.42−$26,71073,073Direct
Dec 3, 2021Common StockSSaleDisposed−1,200$53.49−$64,18871,873Direct
Dec 3, 2021Common StockSSaleDisposed−2,200$53.46−$117,61269,673Direct
Dec 3, 2021Common StockSSaleDisposed−2,719$53.50−$145,466.566,954Direct
Dec 3, 2021Common StockSSaleDisposed−2,756$53.40−$147,170.464,198Direct
Dec 3, 2021Common StockSSaleDisposed−3,627$53.38−$193,609.2660,571Direct
Dec 3, 2021Common StockSSaleDisposed−4,727$53.39−$252,374.5355,844Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)